“The financial resources provided by the Series C equity raise continue to bring our FlowerCube concept to more hospitals and ambulatory surgery centers across the United States,” said Oliver Burckhardt, president and CEO of Flower Orthopedics.
Here are five things to know:
1. Flower Orthopedics completed a $4.5 million Series C equity financing.
2. The company plans to use proceeds for working capital to fund growth strategies.
3. Flower Orthopedics created the FlowerCube, a standardized, single-use bone fixation concept designed for operational efficiencies.
4. The FlowerCube includes sterile tools and the disposable nature promotes faster operating room turnover and allows for back-to-back surgical cases.
5. The technology could save hospitals and ASCs 30 percent of the combined implant and instrument costs on each surgical case. There are more than 300 plate options manufactured in partnership with ZRINSKI AG.
More articles on orthopedic devices:
DJO Global to launch Exprt Precision System for knee revisions
Intellijoint Surgical to introduce hip surgery tool in the U.S.
10 things to know about the PRP market through 2020
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
